Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
Clinical trial NCT00977431 · COMPLETED
Trial details
- NCT number
- NCT00977431
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-17
- Primary completion
- 2017-09-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.